<DOC>
	<DOCNO>NCT02299440</DOCNO>
	<brief_summary>The primary objective study assess efficacy ketamine versus placebo short-term ( 72h , i.e . 24h last perfusion ) relief suicidal ideation , measure use BSS hetero questionnaire , patient hospitalize suicide risk .</brief_summary>
	<brief_title>Effects Ketamine Acute Phase Suicidal Ideation</brief_title>
	<detailed_description>The secondary objective study ass : A . The maintenance medium-term effectiveness ketamine resolution suicidal ideation B . The evolution full spectrum suicidality ketamine compare placebo C. The evolution psychic physical pain score ketamine compare placebo D. The evolution Beck Hopelessness score predictor long-term suicide risk , ketamine compare placebo E. The early antidepressant efficacy ketamine depress , uni- bipolar patient F. The somatic psychological tolerance ketamine G. An overall improvement clinical condition patient practitioner H. Creation biological collection future ancillary study dedicate genetic analysis ( microRNA mRNA ) . I . The efficacy ketamine versus placebo short-term ( 72h , i.e . 24h last perfusion ) relief suicidal ideation , measure use BSS self-report questionnaire , patient hospitalize suicide risk .</detailed_description>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>French speaking patient freely hospitalize prevention suicide medium high suicide risk score accord MINI structure interview The patient able understand study carry test perform The patient deem capable give his/her inform consent The patient correctly inform The patient must give his/her inform signed consent . The patient must insure beneficiary health insurance plan . Presence suicidal ideation accord SSI score ( score &gt; 3 ) Negative pregnancy test woman childbearing age The patient participate another interventional study Within past three month , patient participate another interventional study The patient exclusion period determine previous study The patient judicial protection The patient adult guardianship The patient refuse sign consent The patient able understand inform consent Pregnancy breastfeed History schizophrenia psychotic disorder Presence psychotic symptom initial interview Schizoid schizotypic personality disorder Positive urine screen illicit substance , exclude cannabis Substance dependence precede month ( exclude nicotine caffeine ) Concomitant treatment electroconvulsive therapy Unstable somatic pathology Clinically significant anomaly find clinical examination , biological test ECG Nonstabilized hypertension hypertension &gt; 180/100 Known suspect contraindication ketamine ( include interaction ) : hypersensitivity ketamine , hypertension , class IV cardiac insufficiency , history stroke , hepatic cutaneous porphyria , history intracranial hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>treatment acute suicidal ideation</keyword>
	<keyword>ketamine</keyword>
	<keyword>low-dose ketamine</keyword>
</DOC>